Is Eucrates Biomedical Acquisition Corp. (EUCR) a Buy, Sell, or Hold?
NASDAQ : EUCR
Eucrates Biomedical Acquisition Corp. — Earnings Estimates
$10.04 USD
$0 (0.0%)
- Volume
- 12.7K
- Average Volume
- 1.66K
- Market Capitalization
- $42.23M
- P/E Ratio
- 5.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.25
- Year Low
- $9.87
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.03
Annual earnings financials
EUCR financial data with annual/quarterly toggle
Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.